172 related articles for article (PubMed ID: 37531240)
1. Manganese-Based Redox Homeostasis Disruptor for Inducing Intense Ferroptosis/Apoptosis Through xCT Inhibition And Oxidative Stress Injury.
Dong Q; Wang J; Liu J; Zhang L; Xu Z; Kang Y; Xue P
Adv Healthc Mater; 2023 Nov; 12(28):e2301453. PubMed ID: 37531240
[TBL] [Abstract][Full Text] [Related]
2. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound (US)-activated redox dyshomeostasis therapy reinforced by immunogenic cell death (ICD) through a mitochondrial targeting liposomal nanosystem.
Ren J; Zhou J; Liu H; Jiao X; Cao Y; Xu Z; Kang Y; Xue P
Theranostics; 2021; 11(19):9470-9491. PubMed ID: 34646381
[No Abstract] [Full Text] [Related]
4. Targeted Manganese doped silica nano GSH-cleaner for treatment of Liver Cancer by destroying the intracellular redox homeostasis.
Tang H; Li C; Zhang Y; Zheng H; Cheng Y; Zhu J; Chen X; Zhu Z; Piao JG; Li F
Theranostics; 2020; 10(21):9865-9887. PubMed ID: 32863964
[No Abstract] [Full Text] [Related]
5. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors.
Xu Q; Zhan G; Zhang Z; Yong T; Yang X; Gan L
Theranostics; 2021; 11(4):1937-1952. PubMed ID: 33408790
[TBL] [Abstract][Full Text] [Related]
6. ROS-responsive fluorinated polyethyleneimine vector to co-deliver shMTHFD2 and shGPX4 plasmids induces ferroptosis and apoptosis for cancer therapy.
Yang S; Wong KH; Hua P; He C; Yu H; Shao D; Shi Z; Chen M
Acta Biomater; 2022 Mar; 140():492-505. PubMed ID: 34879292
[TBL] [Abstract][Full Text] [Related]
7. Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib.
Wang X; Zhao L; Wang C; Wang L; Wu H; Song X; Wang W; Xu H; Dong X
Acta Biomater; 2023 Mar; 159():237-246. PubMed ID: 36736851
[TBL] [Abstract][Full Text] [Related]
8. 2-Deoxy-d-ribose induces ferroptosis in renal tubular epithelial cells via ubiquitin-proteasome system-mediated xCT protein degradation.
Kim M; Bae JY; Yoo S; Kim HW; Lee SA; Kim ET; Koh G
Free Radic Biol Med; 2023 Nov; 208():384-393. PubMed ID: 37659699
[TBL] [Abstract][Full Text] [Related]
9. Vasodilator oxyfedrine inhibits aldehyde metabolism and thereby sensitizes cancer cells to xCT-targeted therapy.
Otsuki Y; Yamasaki J; Suina K; Okazaki S; Koike N; Saya H; Nagano O
Cancer Sci; 2020 Jan; 111(1):127-136. PubMed ID: 31692172
[TBL] [Abstract][Full Text] [Related]
10. Edaravone, a free radical scavenger, protects against ferroptotic cell death in vitro.
Homma T; Kobayashi S; Sato H; Fujii J
Exp Cell Res; 2019 Nov; 384(1):111592. PubMed ID: 31479686
[TBL] [Abstract][Full Text] [Related]
11. Bioactive Iridium Nanoclusters with Glutathione Depletion Ability for Enhanced Sonodynamic-Triggered Ferroptosis-Like Cancer Cell Death.
Nie T; Zou W; Meng Z; Wang L; Ying T; Cai X; Wu J; Zheng Y; Hu B
Adv Mater; 2022 Nov; 34(45):e2206286. PubMed ID: 36134532
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy-mediated redox homeostasis-controllable nanomedicine for enhanced ferroptosis sensitivity in tumor therapy.
Lin Y; Chen X; Yu C; Xu G; Nie X; Cheng Y; Luan Y; Song Q
Acta Biomater; 2023 Mar; 159():300-311. PubMed ID: 36642338
[TBL] [Abstract][Full Text] [Related]
13. Cystine-glutamate antiporter xCT as a therapeutic target for cancer.
Liu L; Liu R; Liu Y; Li G; Chen Q; Liu X; Ma S
Cell Biochem Funct; 2021 Mar; 39(2):174-179. PubMed ID: 32749001
[TBL] [Abstract][Full Text] [Related]
14. Activatable nanomedicine for overcoming hypoxia-induced resistance to chemotherapy and inhibiting tumor growth by inducing collaborative apoptosis and ferroptosis in solid tumors.
Fu J; Li T; Yang Y; Jiang L; Wang W; Fu L; Zhu Y; Hao Y
Biomaterials; 2021 Jan; 268():120537. PubMed ID: 33260096
[TBL] [Abstract][Full Text] [Related]
15. Solasonine promotes ferroptosis of hepatoma carcinoma cells via glutathione peroxidase 4-induced destruction of the glutathione redox system.
Jin M; Shi C; Li T; Wu Y; Hu C; Huang G
Biomed Pharmacother; 2020 Sep; 129():110282. PubMed ID: 32531676
[TBL] [Abstract][Full Text] [Related]
16. Regulatory network of ferroptosis and autophagy by targeting oxidative stress defense using sulfasalazine in triple-negative breast cancer.
Takatani-Nakase T; Ikushima C; Sakitani M; Nakase I
Life Sci; 2024 Feb; 339():122411. PubMed ID: 38184272
[TBL] [Abstract][Full Text] [Related]
17. The Role of Iron Metabolism, Lipid Metabolism, and Redox Homeostasis in Alzheimer's Disease: from the Perspective of Ferroptosis.
Wu L; Xian X; Tan Z; Dong F; Xu G; Zhang M; Zhang F
Mol Neurobiol; 2023 May; 60(5):2832-2850. PubMed ID: 36735178
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress-amplified nanomedicine for intensified ferroptosis-apoptosis combined tumor therapy.
Yu M; Yu J; Yi Y; Chen T; Yu L; Zeng W; Ouyang XK; Huang C; Sun S; Wang Y; Liu Y; Lin C; Wu M; Mei L
J Control Release; 2022 Jul; 347():104-114. PubMed ID: 35513212
[TBL] [Abstract][Full Text] [Related]
19. Dual GSH-exhausting sorafenib loaded manganese-silica nanodrugs for inducing the ferroptosis of hepatocellular carcinoma cells.
Tang H; Chen D; Li C; Zheng C; Wu X; Zhang Y; Song Q; Fei W
Int J Pharm; 2019 Dec; 572():118782. PubMed ID: 31678528
[TBL] [Abstract][Full Text] [Related]
20. GSH-responsive degradable nanodrug for glucose metabolism intervention and induction of ferroptosis to enhance magnetothermal anti-tumor therapy.
Liao Z; Wen E; Feng Y
J Nanobiotechnology; 2024 Apr; 22(1):147. PubMed ID: 38570829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
